Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Validation of Alexa-647-ATP as a powerful tool to study P2X receptor ligand binding and desensitization.

Bhargava Y, Nicke A, Rettinger J.

Biochem Biophys Res Commun. 2013 Aug 23;438(2):295-300. doi: 10.1016/j.bbrc.2013.07.058. Epub 2013 Jul 26.

PMID:
23896604
2.

Involvement of the cysteine-rich head domain in activation and desensitization of the P2X1 receptor.

Lörinczi É, Bhargava Y, Marino SF, Taly A, Kaczmarek-Hájek K, Barrantes-Freer A, Dutertre S, Grutter T, Rettinger J, Nicke A.

Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11396-401. doi: 10.1073/pnas.1118759109. Epub 2012 Jun 27.

3.

Allosteric nature of P2X receptor activation probed by photoaffinity labelling.

Bhargava Y, Rettinger J, Mourot A.

Br J Pharmacol. 2012 Nov;167(6):1301-10. doi: 10.1111/j.1476-5381.2012.02083.x.

4.

Aminoglycoside block of P2X2 receptors heterologously expressed in Xenopus laevis oocytes.

Bongartz EV, Rettinger J, Hausmann R.

Purinergic Signal. 2010 Dec;6(4):393-403. doi: 10.1007/s11302-010-9204-9. Epub 2010 Nov 16.

5.

Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.

Baqi Y, Hausmann R, Rosefort C, Rettinger J, Schmalzing G, Müller CE.

J Med Chem. 2011 Feb 10;54(3):817-30. Epub 2011 Jan 5.

PMID:
21207957
6.

A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice.

Nicke A, Kuan YH, Masin M, Rettinger J, Marquez-Klaka B, Bender O, Górecki DC, Murrell-Lagnado RD, Soto F.

J Biol Chem. 2009 Sep 18;284(38):25813-22. doi: 10.1074/jbc.M109.033134. Epub 2009 Jun 22.

7.

Inter-subunit disulfide cross-linking in homomeric and heteromeric P2X receptors.

Marquez-Klaka B, Rettinger J, Nicke A.

Eur Biophys J. 2009 Mar;38(3):329-38. doi: 10.1007/s00249-008-0325-9. Epub 2008 Apr 22.

PMID:
18427801
8.
9.
10.
11.

Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.

Rettinger J, Braun K, Hochmann H, Kassack MU, Ullmann H, Nickel P, Schmalzing G, Lambrecht G.

Neuropharmacology. 2005 Mar;48(3):461-8.

PMID:
15721178
12.

Assembly of nicotinic alpha7 subunits in Xenopus oocytes is partially blocked at the tetramer level.

Nicke A, Thurau H, Sadtler S, Rettinger J, Schmalzing G.

FEBS Lett. 2004 Sep 24;575(1-3):52-8.

13.

Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes.

Aschrafi A, Sadtler S, Niculescu C, Rettinger J, Schmalzing G.

J Mol Biol. 2004 Sep 3;342(1):333-43.

PMID:
15313628
14.

Desensitization masks nanomolar potency of ATP for the P2X1 receptor.

Rettinger J, Schmalzing G.

J Biol Chem. 2004 Feb 20;279(8):6426-33. Epub 2003 Nov 18.

15.
16.

Monomeric and dimeric byproducts are the principal functional elements of higher order P2X1 concatamers.

Nicke A, Rettinger J, Schmalzing G.

Mol Pharmacol. 2003 Jan;63(1):243-52.

PMID:
12488557
17.

NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.

Braun K, Rettinger J, Ganso M, Kassack M, Hildebrandt C, Ullmann H, Nickel P, Schmalzing G, Lambrecht G.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Sep;364(3):285-90.

PMID:
11521173
18.

The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.

Rettinger J, Schmalzing G, Damer S, Müller G, Nickel P, Lambrecht G.

Neuropharmacology. 2000 Aug 23;39(11):2044-53.

PMID:
10963748
19.

Roles of individual N-glycans for ATP potency and expression of the rat P2X1 receptor.

Rettinger J, Aschrafi A, Schmalzing G.

J Biol Chem. 2000 Oct 27;275(43):33542-7.

20.

The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors.

Lambrecht G, Rettinger J, Bäumert HG, Czeche S, Damer S, Ganso M, Hildebrandt C, Niebel B, Spatz-Kümbel G, Schmalzing G, Mutschler E.

Eur J Pharmacol. 2000 Jan 17;387(3):R19-21.

PMID:
10650184
21.

Novel ligands for P2 receptor subtypes in innervated tissues.

Lambrecht G, Damer S, Niebel B, Czeche S, Nickel P, Rettinger J, Schmalzing G, Mutschler E.

Prog Brain Res. 1999;120:107-17.

PMID:
10550991
22.

Evolving view of quaternary structures of ligand-gated ion channels.

Nicke A, Rettinger J, Büttner C, Eichele A, Lambrecht G, Schmalzing G.

Prog Brain Res. 1999;120:61-80. Review. No abstract available.

PMID:
10550988
23.
24.

Blue native PAGE as a useful method for the analysis of the assembly of distinct combinations of nicotinic acetylcholine receptor subunits.

Nicke A, Rettinger J, Mutschler E, Schmalzing G.

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):493-507.

PMID:
10071780
25.

NF279: a novel potent and selective antagonist of P2X receptor-mediated responses.

Damer S, Niebel B, Czeche S, Nickel P, Ardanuy U, Schmalzing G, Rettinger J, Mutschler E, Lambrecht G.

Eur J Pharmacol. 1998 May 29;350(1):R5-6.

PMID:
9683026
26.

Voltage-dependent inhibition of the Na+,K+ pump by tetraethylammonium.

Eckstein-Ludwig U, Rettinger J, Vasilets LA, Schwarz W.

Biochim Biophys Acta. 1998 Jul 17;1372(2):289-300.

27.

P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.

Nicke A, Bäumert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E, Schmalzing G.

EMBO J. 1998 Jun 1;17(11):3016-28.

29.

Ion-selective channels in K562 cells: a patch-clamp analysis.

Rettinger J, Schwarz W.

J Basic Clin Physiol Pharmacol. 1994 Jan-Mar;5(1):27-44.

PMID:
8736069
30.

Inward-directed current generated by the Na+,K+ pump in Na(+)- and K(+)-free medium.

Efthymiadis A, Rettinger J, Schwarz W.

Cell Biol Int. 1993 Dec;17(12):1107-16.

PMID:
8118453

Supplemental Content

Loading ...
Support Center